chrisvoncsefalvay/vaers-outcomes huggingface dataset:
throat being slightly swollen; lymph node is swollen like it hurts; lymph node is swollen like it hurts; her jaw and ear hurting; her jaw and ear hurting; her throat hurting; neck hurting; This is a spontaneous report from a contactable consumer or other non hcp. A 45-year-old female patient received bnt162b2 (COMIRNATY; Formulation: Solution for injection, Batch/Lot Number: FA6780), via an unspecified route of administration, administered in Arm Left on 23Jul2021 at 12:00) (at the age of 45-year-old) as Dose 1, Single for covid-19 immunization. The patient medical history included diabetes mellitus from an unknown date and unknown if ongoing and to help the kidneys (Kidney disorder). Concomitant medications included metformin hydrochloride, sitagliptin phosphate monohydrate and insulin glargine taken for diabetes mellitus from an unspecified start date and ongoing, liraglutide, lisinopril (to help the kidneys) and rosuvastatin calcium taken for an unspecified indication from an unspecified start date and ongoing, omeprazole taken for dyspepsia from an unspecified start date and ongoing, lurasidone hydrochloride taken for depression from an unspecified start date and ongoing and clonazepam taken for anxiety from an unspecified start date and ongoing. On 24Jul2021 (the next day after vaccination), the patient started to have complaints of her throat hurting, neck hurting. On 25Jul2021, she had complaints on her jaw and ear hurting. On 29Jul2021, the patient had complaints in her throat being slightly swollen and jaw pain. The patient also experienced jaw and ear hurting, throat being slightly swollen, lymph node is swollen like it hurts, lymph node is swollen like it hurts on an unspecified date. The patient underwent lab tests and procedures which included glycosylated haemoglobin: unknown on an unspecified date. After she took it, her throat started hurting and so far, she has had no trouble swallowing but, her neck has been hurting. Sunday night, it went up into her jaw and into her ear. The patient went to the emergency room and waited for 8hours, so she did not stay. She has been trying to get in touch with her doctor all week and call it in. Was trying for a same day appointment but has not been able to get it. Therapeutic measures were taken as a result of her throat hurting, her jaw and ear hurting, her jaw and ear hurting, throat being slightly swollen, lymph node is swollen, like it hurts, lymph node is swollen like it hurts and neck hurting. The clinical outcome of all the events were not recovered.  No follow-up attempts are possible, no further information is expected.
For 8 days after vaccination I had the usual fever, body aches, chills and fatigue. Then suddenly I started having pain down my left arm and into the front of my armpit. I was concerned of cardiac arrest. I was having trouble with my breathing but not short of breath. It was like I could not catch my breath like I could not fill my lungs full.
Patient stated she had fever, chills, aches and pain from SHINGRIX and/or Flu vaccine.
Chest Pain, burning, sharp, stabbing all the way to my back.  Shortness off breath.
My arm got stiff and sore from the shoulder down.   It has continued to be stiff and sore for almost 3 weeks.   Seeing the doctor today.  I had the shot in my dominate arm as suggested and moved it around real good the first 3 days.  Now I'm trying to figure out if I should be moving it or resting it.  The shot was given higher up on my arm than what I've had in the past, not sure it that could make a difference or not.
AFTER PT RECIEVED THREE VACCINES, HE STATED HE FELT DIZZY, SLUMPED OVER IN CHAIR. I HELD PT UPRIGHT FOR APPROX 10 SECONDS UNTIL HE CAME AROUND AND WAS ABLE TO RESPOND TO QUESTIONS. ASSISTED PT TO LYING POSITION. APPLED ICE TO BACK OF NECK. AFTER LYING FOR A FEW MINUTES, HE SAT UP AND ATE A GRANOLA BAR GRANDMOTHER HAD AND DRANK A JUICE. OBSERVED FOR APPROX 10 MORE MINUTE UNTIL HE STATED HE FELT BETTER AND LEFT THE OFFICE.
This spontaneous report was received from a licensed practical nurse (L.P.N.) and refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 25-NOV-2015, the patient was accidentally vaccinated with an expired dose of RECOMBIVAX HB (lot # K004989, expiration date 14-NOV-2015; dose and route of administration were not reported). Concomitant therapy was not provided. No adverse effects were reported. Additional information has been requested.
Patient experienced Brain fog; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Patient experienced Brain fog) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    No Medical History information was reported.   On 04-May-2022, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) CF, solution for injection in pre-filled pen. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In July 2022, the patient experienced FEELING ABNORMAL (Patient experienced Brain fog). At the time of the report, FEELING ABNORMAL (Patient experienced Brain fog) had not resolved.            Concomitant drugs were not reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  The reporter's causality for the event of Patient experienced Brain fog with humira was not provided.  Treatment details were not given.   Reporter did not allow further contact
This study case was received from an investigator in a trial on 06 June 2011. A 23 year-old female subject with no significant medical history was found to have acute idiopathic pericarditis 13 days after she had received an injection of ACAM2000 (lot number, route and site of administration not reported) and ANTHRAX 1 (manufacturer, lot number, route and site of administration not reported) on 11 February 2011. Relevant laboratory data included: a normal Troponin I result, a normal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
large area approx. 4 inches by 4 inches on the upper arm at the injection site which is red, raised and hot to the touch; is not responding to treatment with antihistimine and ice
The patient developed hives/rash over her entire body. This began approximately 1 hour following the injection. The patient was treated with Medrol dose pack, oral Benadryl and Benadryl cream.
3 small ball an my collarbone and one on neck; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (3 small ball an my collarbone and one on neck) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (3 small ball an my collarbone and one on neck). At the time of the report, LYMPHADENOPATHY (3 small ball an my collarbone and one on neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information was unknown.
Symptoms: Cough, Altered Mental Status,  chest congestion. Treatment: oxygen, remdesivir.ceftriaxone , nebulizer treatment and Spiriva  Outcomes: still in the hospital 9/28/2021
Information has been received on 07-APR-2017 from an other health professional via a company representative regarding a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapy were not reported. On an unknown date the patient was vaccinated with a fourth dose of GARDASIL 9, (lot number and expiration not reported) intramuscular for prophylaxis which is other than indicated in the prescribing information. No adverse event reported. No further information was provided. Additional information has been requested.
pt exp poss allerg rxn, flu shot hurt @ time of inj, burning sensation in arm when given;11/2hr later feeling dizzy & nauseated;BP lt 120/68;diff breathing, t99.6;wheezing, SOB, 02 started;dx as rxn to flu vax;
headache; This is a spontaneous report from a contactable consumer. A 42-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number: EL8982, via an unspecified route of administration, administered in left arm on 10Feb2021 as single dose for COVID-19 immunisation. Medical history included COVID-19 from Oct2020 (tested positive for Covid). Concomitant medications were not reported. The patient is not pregnant. On 16Feb2021, the patient started to develop a headache. This headache increased substantially to a 10 out of 10 on a pain scale. On Sunday, 21Feb2021, the patient went into the ER. Again, on 26Feb2021 after consult with neurologist. Current headache has started to subside, the patient received second dose on 04Mar2021. Relevant lab test and procedures were done on an unspecified date which included computerised tomogram (CT), magnetic resonance imaging (MRI) and spinal tap; all unknown results. The patient has tested negative for COVID-19 test on 26Feb2021. The patient received unspecified pain meds and blood pressure medication as treatment. The outcome of the event was recovering.
On the morning of 4/7/03, pt. developed diarrhea resolved with Immodium.  At approximately 6 pm of 4/7/03, pt. developed abdominal and chest pains, diaphoresis, and syncope. Pt. given 3 infant aspirin and sublingual Nitroglyercin x 2 without relief at place of work (hospital).  Taken to ER -BP measured 48/27, EKG abnormal (ST segment elevation, poor R wave).  Admitted to cardiology at Medical Center.  Discharged on 4/10/03.  Dx: Hypotension with hypovolemia.
4 days after receiving TD booster and skin test client called complaining of hives on face and arms, right arm swollen and painful.  Client instructed to seek medical follow up at ER or PCP.
Patient states she has been ill ever since she received her second dose of moderna shot. Cold symptoms, fever, chills, no energy to get out of bed. lab work values altered. she states she has seen mutiple specialists since (cardiologist, rheumatologist, gastroenterologist)  with no relief.
Had constant crying for 3 - 3 hours after 1st set of immunizations on 9-9-09 @ 2mm of age with some fever per parents. (received pediatric otc 4mm without problems). Parents called day of immunizations + day after reporting pt cried 2 - 3 hours, with 4mm when reported pt cried 10 hours 8 pm -> 6 am.
nerve pain; itch cones and goes; stressed; suspected vaccination failure/had shingles last October, had the shots in 2019; shingles/had shingles last October, had the shots in 2019; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In October 2021, more than a year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the patient experienced post herpetic neuralgia, pruritus and stress. On an unknown date, the outcome of the vaccination failure, shingles and stress were unknown and the outcome of the post herpetic neuralgia and pruritus were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, post herpetic neuralgia, pruritus and stress to be related to Shingles vaccine.     Additional Information: GSK receipt date: 25-Aug-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had shingles last October and he/she still have had the nerve pain and itch comes and gones. The patient called the pharmacy to get the shots and they said they could not give vaccine to him/her because he/she already had the shots in fall of 2019. The patient called his/her phyisican and he said that the patient had to wait 5 years. The patient was so stressed. The patient did not want to get shingles again. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
pt recvd vax & exp extreme fatigue & weakness, back pain, h/a daily, achey, irregular heartbeats, sweats, blurrey vision, diff w/concentration
patient reported tightened airway, lightheaded BP 129/79 99%, reports she has anxiety attacks,  emotional reassurance given.  Tolerating H2O  At 1322 patient reports feeling much better 114/83 78.
Fever; Chills; Nausea; Multiple vomiting incidents; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 21Apr2021 at 08:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included ascorbic acid (VITAMIN C) and vitamin d nos (MANUFACTURER UNKNOWN); both for unknown indications from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 31Mar2021 at 08:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 20:30, the patient experienced fever, chills, nausea and multiple vomiting incidents. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, nausea and multiple vomiting incidents was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Fever for two days, chills, fatigue, swollen/pain under armpit of where shot was given, muscle pain and aches. Advised to move arm a lot, take Motrin after shot, then again before bed. Did that, then took Motrin the next day too. On day 3 symptoms are better but not totally gone.
Approx. 24 hours after 2nd shot, a very large swollen lump appeared at injection site. It is more than 3? in diameter, very hot to the touch, and very itchy.  A rash has also appeared around the edges of the soles of my feet.
warm to touch; itchy; a red area at the injection site; it is a little smaller than palm size; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INJECTION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itchy), INJECTION SITE ERYTHEMA (a red area at the injection site) and INJECTION SITE SWELLING (it is a little smaller than palm size) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced INJECTION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itchy), INJECTION SITE ERYTHEMA (a red area at the injection site) and INJECTION SITE SWELLING (it is a little smaller than palm size). At the time of the report, INJECTION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itchy) and INJECTION SITE SWELLING (it is a little smaller than palm size) outcome was unknown and INJECTION SITE ERYTHEMA (a red area at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment included Pepcid.
Vaccine on the 10th, Left thigh into knee swollen and sore on 11th, Right knee down to mid  top foot swollen, red and feverish on the 12th (pt. could not walk). Admitted to hospital. Variety of test (all neg). Pt given steroids, antihistamines during visit was sent home on steroids. 7/14/09 x 5 days (Sunday) 7/19/09. Patient received vaccination on July 10, 2009. On July 11, 2009 his left thigh all the way down into the middle part of his left knee was swollen and sore. By the afternoon of Sunday, July 12, 2009, Patient's right knee all the way down to his right mid foot was swollen, red, and hot to the touch and was unable to walk. He was admitted to the hospital, all the test came back negative. He was put on Steroids and antihistamines during his hospital stay. He was sent home on Steroids for five days which ended on Sunday, July 19, 2009. On Thursday, July 23, 2009 my son started having hives on his legs, I gave him BENADRYL and 1 1/2 later, they had spread all over his body which resulted in me taking him to Pediatrics, for the forth time in less than 2 weeks. There he was put back on steroids for two days and I took him to his pediatrician on Friday, July 24, 2009, where she, put him on ATARAX, and gave me a prescription for an epi-penJr., Sunday the 26th was his last day of steroids and today is Tuesday July 28, 2009 and he still has the hives and itching, his skin in now blotchy and bruised, and red in some spots from his head down to his ankles. He had no problems like this before immunization (Hepatitis A) was given, in which he was diagnosed at hospital as being allergic to, but he has had that one before, but Polio/DTaP (KINREX) he has never had, so I am assuming that he had an allergic reaction to that one.  8/12/09 Hospital records received DOS 7/12/09 to 7/14/09. Assessment: Lower extremity rash - resolving. Pain - resolved. Swelling - resolved. Lymphadenopathy - resolving. Limp - resolved. Contact dermatitis.  Patient c/o right calf and ankle pain/swelling with concurrent decreased activity. Limping. Nodules posterior aspect of thighs. On admission new onset ecchymosis on right lower extremity. Large nodule on posterior of right thigh. Posterior cervical lymphadenopathy. Dry erythematous papules bilateral lower extremities. Unable to walk. Thighs tender and warm.
Reported to the ED on 06/05/2013 with redness and inflammatory response on left arm. Patient was started on minocycline on the same day of vaccine (06/03/2013) for lesion on his back +MRSA and serratia. Redness and local inflammation of arm.
This case was reported by a consumer via call center representative and described the occurrence of generalized erythema in a 79-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included paraproteinemia and breast cancer. Concurrent medical conditions included monoclonal gammopathy. On 4th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 20th May 2018, 16 days after receiving SHINGRIX, the patient experienced generalized erythema, generalized urticaria and generalized pruritus. On an unknown date, the outcome of the generalized erythema, generalized urticaria and generalized pruritus were unchanged. It was unknown if the reporter considered the generalized erythema, generalized urticaria and generalized pruritus to be related to SHINGRIX. Additional details were provided as follows: The patient started experiencing redness, itching and welts all over the body. It started with itching and when she puts pressure on the area it became red. The areas mostly affected were trunk of the body, underneath the bra, arms, and legs. The itching was on and off. She had an autoimmune disease: monoclonal gammopathy (MGUF), and monoclonal Paraproteinemia. On 22nd June 2018 and on 11th July 2018, the patient had been visited to her primary care doctor. The patient had followed up appointment with her oncologist in 2 to 3 weeks (from the date of reporting).
Severe shoulder and arm pain, weakness, numbness finger tips. Diagnosed with Parsonage Turner Syndrome
01/19/2021 a couple weeks after my period was very irregular, I would miss cycles and a month after I was having UTI back to back, I went to hospital in September 2021 and it ended up being a Kidney Infection,  My pediatrician referred me to Urologists which I'm still waiting on that appointment. I was given an antibiotic at my pediatrician's office, I don't remember the name, It didn't seemed to help so they ended up switching to a capsule antibiotic that was back and yellow. As of right now I still have this ongoing issue.
adverse events; possible allergic reaction; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (adverse events) and HYPERSENSITIVITY (possible allergic reaction) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse events) and HYPERSENSITIVITY (possible allergic reaction). At the time of the report, VACCINATION COMPLICATION (adverse events) and HYPERSENSITIVITY (possible allergic reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
12 days post 3rd dose of Moderna "booster" COVID-19 vaccine I began to develop spontaneous urticaria which occurs both randomly and brought on by light scratching, touching, etc.  During these incidents I break out in wheals, often in the shape of the scratch or touch, which are surrounded by redness.  The wheals begin first and then smaller spots more like hives will form secondary to the initial site.  These issues have occurred on all locations on my body, but they tend to be on my trunk and arms more often.  This has been occurring for 3 days now.  I am using OTC antihistamines to control the severity of the occurrences, however it remains very active.